Vascular dementia trial of Viagra-type drug nears closing stages

May 21, 2018, St. George's University of London
Credit: St. George's University of London

The Phase 2 trial (named PASTIS) is examining whether tadalafil – a Viagra-like drug that treats erectile dysfunction – can increase blood flow to the deep vessels within the brain.

Vascular is the second most prevalent cause of dementia, after Alzheimers' disease. Increasingly it is clear that changes to blood vessels within the brain could worsen dementia and speed cognitive decline.

The trial at St George's is being led by a Neuroscientist Dr. Atticus Hainsworth and funded by the Alzheimer's Society and a US charity, the Alzheimer's Drug Discovery Foundation. Consultant Neurologist Dr. Jeremy Isaacs of St George's Hospital is the clinical principal investigator.

The researchers recruited 55 older people with symptomatic small vessel disease. Over the course of two visits they were given either a tadalafil pill or a placebo. They had an MRI scan both before, and 3-5 hours after the dose was given.

Dr. Hainsworth explained: "All patients have now been scanned and we are analyzing the scans. After that we will unlock the trial and find out whether the drug did increase brain . While the exposure was very brief, we hope it will give us a clear picture of the difference the made, and allow us to build on this in future trials."

Dr. Hainsworth is also the lead of the Vascular Experimental Medicine group within Dementias Platform UK, a public-private partnership created by the Medical Research Council (MRC) to facilitate the discovery of new ways to understand, diagnose, and treat dementia.

He commented: "This links all the different dementia groups and researchers in the UK and is essential to ensure that we are all working together to make progress against this group of disorders, which affects 850,000 people in the UK."

Explore further: Drugs used for impotence could treat vascular dementia?

Related Stories

Drugs used for impotence could treat vascular dementia?

December 11, 2014
Scientists are to explore whether drugs usually used to treat erectile problems by expanding blood vessels could become the next major way to tackle the dementia epidemic.

Faults in the blood-brain barrier implicated in dementia

February 6, 2018
California based researchers have found that damage to cells known as pericytes, which surround small blood vessels in the brain, may trigger a chain of events that results in brain degeneration. The findings are published ...

Positive results from Alzheimer's drug in Phase 1 clinical trial extension

November 3, 2017
The pharmaceutical company Biogen has today announced the results of an extended phase 1b clinical trial of the potential Alzheimer's disease drug, aducanumab. Results from the extended early stage trial, were announced today ...

High blood pressure linked to vascular dementia

May 18, 2016
High blood pressure could significantly raise the risk of developing the second most common form of dementia, according to a new study from The George Institute for Global Health.

Tiny blood vessels in the brain could be the key in treating vascular dementia

June 22, 2017
Researchers from the University of Southampton are to study tiny channels embedded in the walls of blood vessels in the brain to assess their impact on dementia.

Alzheimer's drug targeting soluble amyloid falls short in a large clinical trial

January 25, 2018
A paper published today in the New England Journal of Medicine reports that solanezumab, a monoclonal antibody-based treatment for Alzheimer's disease developed by Eli Lilly that targets amyloid plaques, did not significantly ...

Recommended for you

Hypothesis underpinning dementia research 'flawed'

October 16, 2018
A hypothesis which has been the standard way of explaining how the body develops Alzheimer's Disease for almost 30 years is flawed, according to a University of Manchester biologist.

Many cases of dementia may arise from non-inherited DNA 'spelling mistakes'

October 15, 2018
Only a small proportion of cases of dementia are thought to be inherited—the cause of the vast majority is unknown. Now, in a study published today in the journal Nature Communications, a team of scientists led by researchers ...

Scientists create new map of brain region linked to Alzheimer's disease

October 8, 2018
Curing some of the most vexing diseases first requires navigating the world's most complex structure—the human brain. So, USC scientists have created the most detailed atlas yet of the brain's memory bank.

Previously unknown genetic aberrations found to be associated with Alzheimer's progression

October 8, 2018
In a large-scale analysis of RNA from postmortem human brain tissue, researchers at the Icahn School of Medicine at Mount Sinai and Columbia University have identified specific RNA splicing events associated with Alzheimer's ...

Periodontal disease bacteria may kick-start Alzheimer's

October 4, 2018
Long-term exposure to periodontal disease bacteria causes inflammation and degeneration of brain neurons in mice that is similar to the effects of Alzheimer's disease in humans, according to a new study from researchers at ...

AI could predict cognitive decline leading to Alzheimer's disease in the next five years

October 4, 2018
A team of scientists has successfully trained a new artificial intelligence (AI) algorithm to make accurate predictions regarding cognitive decline leading to Alzheimer's disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.